Report cover image

Global Nanoemulsions Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 194 Pages
SKU # APRC20284018

Description

Summary

According to APO Research, The global Nanoemulsions market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Nanoemulsions is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nanoemulsions is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Nanoemulsions is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Nanoemulsions is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Nanoemulsions include Sanofi, Novartis AG, GlaxoSmithKline plc, AbbVie Inc., Kaken Pharmaceutical Co., Ltd., Fresenius Kabi AG, B. Braun Melsungen AG., AstraZeneca Inc. and Allergan plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nanoemulsions, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Nanoemulsions, also provides the revenue of main regions and countries. Of the upcoming market potential for Nanoemulsions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nanoemulsions revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Nanoemulsions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Nanoemulsions revenue, projected growth trends, production technology, application and end-user industry.

Nanoemulsions Segment by Company

Sanofi
Novartis AG
GlaxoSmithKline plc
AbbVie Inc.
Kaken Pharmaceutical Co., Ltd.
Fresenius Kabi AG
B. Braun Melsungen AG.
AstraZeneca Inc.
Allergan plc
Nanoemulsions Segment by Type

NSAIDs
Antimicrobials
Antiretroviral
Steroids
Anesthetics
Immunosuppressant
Vasodilators
Others
Nanoemulsions Segment by Application

Cosmetic Industrial
Food Industrial
Pharmaceutical Industrial
Others
Nanoemulsions Segment by Region

North America
United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Colombia
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanoemulsions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanoemulsions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanoemulsions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Nanoemulsions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Nanoemulsions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanoemulsions revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Nanoemulsions Market by Type
1.2.1 Global Nanoemulsions Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 NSAIDs
1.2.3 Antimicrobials
1.2.4 Antiretroviral
1.2.5 Steroids
1.2.6 Anesthetics
1.2.7 Immunosuppressant
1.2.8 Vasodilators
1.2.9 Others
1.3 Nanoemulsions Market by Application
1.3.1 Global Nanoemulsions Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cosmetic Industrial
1.3.3 Food Industrial
1.3.4 Pharmaceutical Industrial
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Nanoemulsions Market Dynamics
2.1 Nanoemulsions Industry Trends
2.2 Nanoemulsions Industry Drivers
2.3 Nanoemulsions Industry Opportunities and Challenges
2.4 Nanoemulsions Industry Restraints
3 Global Growth Perspective
3.1 Global Nanoemulsions Market Perspective (2020-2031)
3.2 Global Nanoemulsions Growth Trends by Region
3.2.1 Global Nanoemulsions Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Nanoemulsions Market Size by Region (2020-2025)
3.2.3 Global Nanoemulsions Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Nanoemulsions Revenue by Players
4.1.1 Global Nanoemulsions Revenue by Players (2020-2025)
4.1.2 Global Nanoemulsions Revenue Market Share by Players (2020-2025)
4.1.3 Global Nanoemulsions Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Nanoemulsions Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Nanoemulsions Key Players Headquarters & Area Served
4.4 Global Nanoemulsions Players, Product Type & Application
4.5 Global Nanoemulsions Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Nanoemulsions Market CR5 and HHI
4.6.3 2024 Nanoemulsions Tier 1, Tier 2, and Tier 3
5 Nanoemulsions Market Size by Type
5.1 Global Nanoemulsions Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Nanoemulsions Revenue by Type (2020-2031)
5.3 Global Nanoemulsions Revenue Market Share by Type (2020-2031)
6 Nanoemulsions Market Size by Application
6.1 Global Nanoemulsions Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Nanoemulsions Revenue by Application (2020-2031)
6.3 Global Nanoemulsions Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Comapny Information
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Nanoemulsions Revenue and Gross Margin (2020-2025)
7.1.4 Sanofi Nanoemulsions Product Portfolio
7.1.5 Sanofi Recent Developments
7.2 Novartis AG
7.2.1 Novartis AG Comapny Information
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Nanoemulsions Revenue and Gross Margin (2020-2025)
7.2.4 Novartis AG Nanoemulsions Product Portfolio
7.2.5 Novartis AG Recent Developments
7.3 GlaxoSmithKline plc
7.3.1 GlaxoSmithKline plc Comapny Information
7.3.2 GlaxoSmithKline plc Business Overview
7.3.3 GlaxoSmithKline plc Nanoemulsions Revenue and Gross Margin (2020-2025)
7.3.4 GlaxoSmithKline plc Nanoemulsions Product Portfolio
7.3.5 GlaxoSmithKline plc Recent Developments
7.4 AbbVie Inc.
7.4.1 AbbVie Inc. Comapny Information
7.4.2 AbbVie Inc. Business Overview
7.4.3 AbbVie Inc. Nanoemulsions Revenue and Gross Margin (2020-2025)
7.4.4 AbbVie Inc. Nanoemulsions Product Portfolio
7.4.5 AbbVie Inc. Recent Developments
7.5 Kaken Pharmaceutical Co., Ltd.
7.5.1 Kaken Pharmaceutical Co., Ltd. Comapny Information
7.5.2 Kaken Pharmaceutical Co., Ltd. Business Overview
7.5.3 Kaken Pharmaceutical Co., Ltd. Nanoemulsions Revenue and Gross Margin (2020-2025)
7.5.4 Kaken Pharmaceutical Co., Ltd. Nanoemulsions Product Portfolio
7.5.5 Kaken Pharmaceutical Co., Ltd. Recent Developments
7.6 Fresenius Kabi AG
7.6.1 Fresenius Kabi AG Comapny Information
7.6.2 Fresenius Kabi AG Business Overview
7.6.3 Fresenius Kabi AG Nanoemulsions Revenue and Gross Margin (2020-2025)
7.6.4 Fresenius Kabi AG Nanoemulsions Product Portfolio
7.6.5 Fresenius Kabi AG Recent Developments
7.7 B. Braun Melsungen AG.
7.7.1 B. Braun Melsungen AG. Comapny Information
7.7.2 B. Braun Melsungen AG. Business Overview
7.7.3 B. Braun Melsungen AG. Nanoemulsions Revenue and Gross Margin (2020-2025)
7.7.4 B. Braun Melsungen AG. Nanoemulsions Product Portfolio
7.7.5 B. Braun Melsungen AG. Recent Developments
7.8 AstraZeneca Inc.
7.8.1 AstraZeneca Inc. Comapny Information
7.8.2 AstraZeneca Inc. Business Overview
7.8.3 AstraZeneca Inc. Nanoemulsions Revenue and Gross Margin (2020-2025)
7.8.4 AstraZeneca Inc. Nanoemulsions Product Portfolio
7.8.5 AstraZeneca Inc. Recent Developments
7.9 Allergan plc
7.9.1 Allergan plc Comapny Information
7.9.2 Allergan plc Business Overview
7.9.3 Allergan plc Nanoemulsions Revenue and Gross Margin (2020-2025)
7.9.4 Allergan plc Nanoemulsions Product Portfolio
7.9.5 Allergan plc Recent Developments
8 North America
8.1 North America Nanoemulsions Revenue (2020-2031)
8.2 North America Nanoemulsions Revenue by Type (2020-2031)
8.2.1 North America Nanoemulsions Revenue by Type (2020-2025)
8.2.2 North America Nanoemulsions Revenue by Type (2026-2031)
8.3 North America Nanoemulsions Revenue Share by Type (2020-2031)
8.4 North America Nanoemulsions Revenue by Application (2020-2031)
8.4.1 North America Nanoemulsions Revenue by Application (2020-2025)
8.4.2 North America Nanoemulsions Revenue by Application (2026-2031)
8.5 North America Nanoemulsions Revenue Share by Application (2020-2031)
8.6 North America Nanoemulsions Revenue by Country
8.6.1 North America Nanoemulsions Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Nanoemulsions Revenue by Country (2020-2025)
8.6.3 North America Nanoemulsions Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Nanoemulsions Revenue (2020-2031)
9.2 Europe Nanoemulsions Revenue by Type (2020-2031)
9.2.1 Europe Nanoemulsions Revenue by Type (2020-2025)
9.2.2 Europe Nanoemulsions Revenue by Type (2026-2031)
9.3 Europe Nanoemulsions Revenue Share by Type (2020-2031)
9.4 Europe Nanoemulsions Revenue by Application (2020-2031)
9.4.1 Europe Nanoemulsions Revenue by Application (2020-2025)
9.4.2 Europe Nanoemulsions Revenue by Application (2026-2031)
9.5 Europe Nanoemulsions Revenue Share by Application (2020-2031)
9.6 Europe Nanoemulsions Revenue by Country
9.6.1 Europe Nanoemulsions Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Nanoemulsions Revenue by Country (2020-2025)
9.6.3 Europe Nanoemulsions Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Nanoemulsions Revenue (2020-2031)
10.2 China Nanoemulsions Revenue by Type (2020-2031)
10.2.1 China Nanoemulsions Revenue by Type (2020-2025)
10.2.2 China Nanoemulsions Revenue by Type (2026-2031)
10.3 China Nanoemulsions Revenue Share by Type (2020-2031)
10.4 China Nanoemulsions Revenue by Application (2020-2031)
10.4.1 China Nanoemulsions Revenue by Application (2020-2025)
10.4.2 China Nanoemulsions Revenue by Application (2026-2031)
10.5 China Nanoemulsions Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Nanoemulsions Revenue (2020-2031)
11.2 Asia Nanoemulsions Revenue by Type (2020-2031)
11.2.1 Asia Nanoemulsions Revenue by Type (2020-2025)
11.2.2 Asia Nanoemulsions Revenue by Type (2026-2031)
11.3 Asia Nanoemulsions Revenue Share by Type (2020-2031)
11.4 Asia Nanoemulsions Revenue by Application (2020-2031)
11.4.1 Asia Nanoemulsions Revenue by Application (2020-2025)
11.4.2 Asia Nanoemulsions Revenue by Application (2026-2031)
11.5 Asia Nanoemulsions Revenue Share by Application (2020-2031)
11.6 Asia Nanoemulsions Revenue by Country
11.6.1 Asia Nanoemulsions Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Nanoemulsions Revenue by Country (2020-2025)
11.6.3 Asia Nanoemulsions Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Nanoemulsions Revenue (2020-2031)
12.2 SAMEA Nanoemulsions Revenue by Type (2020-2031)
12.2.1 SAMEA Nanoemulsions Revenue by Type (2020-2025)
12.2.2 SAMEA Nanoemulsions Revenue by Type (2026-2031)
12.3 SAMEA Nanoemulsions Revenue Share by Type (2020-2031)
12.4 SAMEA Nanoemulsions Revenue by Application (2020-2031)
12.4.1 SAMEA Nanoemulsions Revenue by Application (2020-2025)
12.4.2 SAMEA Nanoemulsions Revenue by Application (2026-2031)
12.5 SAMEA Nanoemulsions Revenue Share by Application (2020-2031)
12.6 SAMEA Nanoemulsions Revenue by Country
12.6.1 SAMEA Nanoemulsions Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Nanoemulsions Revenue by Country (2020-2025)
12.6.3 SAMEA Nanoemulsions Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.